Pericardial delta like non‐canonical NOTCH ligand 1 (Dlk1) augments fibrosis in the heart through epithelial to mesenchymal transition
Clinical and Translational Medicine · 2024
DOI: 10.1002/ctm2.1565 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Medicine, 2024. Verfasst von Charlotte Harken Jensen und 17 weiteren Autor:innen. Beteiligte Einrichtung: Andersen Group, Department of Clinical Biochemistry, Odense University Hospital, Odense, Denmark. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Myocardial Infarction. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Region of Southern Denmark, The Danish National Research Council, Lundbeck Foundation.
Abstract (Originalsprache)
Background
Heart failure due to myocardial infarction (MI) involves fibrosis driven by epicardium‐derived cells (EPDCs) and cardiac fibroblasts, but strategies to inhibit and provide cardio‐protection remains poor. The imprinted gene, non‐canonical NOTCH ligand 1 (Dlk1), has previously been shown to mediate fibrosis in the skin, lung and liver, but very little is known on its effect in the heart.
Methods
Herein, human pericardial fluid/plasma and tissue biopsies were assessed for DLK1, whereas the spatiotemporal expression of Dlk1 was determined in mouse hearts. The Dlk1 heart phenotype in normal and MI hearts was assessed in transgenic mice either lacking or overexpressing Dlk1. Finally, in/ex vivo cell studies provided knowledge on the molecular mechanism.
Results
Dlk1 was demonstrated in non‐myocytes of the developing human myocardium but exhibited a restricted pericardial expression in adulthood. Soluble DLK1 was twofold higher in pericardial fluid (median 45.7 [34.7 (IQR)) μg/L] from cardiovascular patients ( n = 127) than in plasma (median 26.1 μg/L [11.1 (IQR)]. The spatial and temporal expression pattern of Dlk1 was recapitulated in mouse and rat hearts. Similar to humans lacking Dlk1, adult Dlk1 −/− mice exhibited a relatively mild developmental, although consistent cardiac phenotype with some abnormalities in heart size, shape, thorax orientation and non‐myocyte number, but were functionally normal. However, after MI, scar size was substantially reduced in Dlk1 −/− hearts as compared with Dlk1 +/+ littermates. In line, high levels of Dlk1 in transgenic mice Dlk1 fl/fl xWT1 GFPCre and Dlk1 fl/fl xαMHC Cre/+Tam increased scar size following MI. Further mechanistic and cellular insight demonstrated that pericardial Dlk1 mediates cardiac fibrosis through epithelial to mesenchymal transition (EMT) of the EPDC lineage by maintaining Integrin β8 ( Itgb8 ), a major activator of transforming growth factor β and EMT.
Conclusions
Our results suggest that pericardial Dlk1 embraces a, so far, unnoticed role in the heart augmenting cardiac fibrosis through EMT. Monitoring DLK1 levels as well as targeting pericardial DLK1 may thus offer new venues for cardio‐protection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Andersen Group, Department of Clinical Biochemistry, Odense University Hospital, Odense, Denmark.
- Clinical Institute, University of Southern Denmark, Odense, Denmark.
- Department of Cardiovascular and Renal Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark.
- Department of Nuclear Medicine, Odense University Hospital, Odense, Denmark.
- Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark.
- Department of Clinical Pathology, Sydvestjysk Hospital, Esbjerg, Denmark.
ORCID-Profile: Ditte Caroline Andersen
Förderung
- The Region of Southern Denmark
- The Danish National Research Council
- Lundbeck Foundation
- Laegeforeningen
- Tømrermester Alfred Andersen og Hustru's Fond
- Hertha Christensens Foundation
- Eva and Henry Fraenkels Foundation
- Odense University Hospital Research Funding
Zitieren
APA
Jensen, C. H., Johnsen, R. H., Eskildsen, T., Baun, C., Ellman, D. G., Fang, S., Bak, S. T., Hvidsten, S., Larsen, L. A., Rosager, A. M., Riber, L. P., Schneider, M., De Mey, J., Thomassen, M., Burton, M., Uchida, S., Laborda, J., & Andersen, D. C. (2024). Pericardial delta like non‐canonical NOTCH ligand 1 (Dlk1) augments fibrosis in the heart through epithelial to mesenchymal transition. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.1565
Vancouver
Jensen CH, Johnsen RH, Eskildsen T, Baun C, Ellman DG, Fang S, et al. Pericardial delta like non‐canonical NOTCH ligand 1 (Dlk1) augments fibrosis in the heart through epithelial to mesenchymal transition. Clinical and Translational Medicine. 2024. doi:10.1002/ctm2.1565
BibTeX
@article{Jensen2024,
author = {Jensen, Charlotte Harken and Johnsen, Rikke Helin and Eskildsen, Tilde and Baun, Christina and Ellman, Ditte Gry and Fang, Shu and Bak, Sara Thornby and Hvidsten, Svend and Larsen, Lars Allan and Rosager, Ann Mari and Riber, Lars Peter and Schneider, Mikael and De Mey, Jo and Thomassen, Mads and Burton, Mark and Uchida, Shizuka and Laborda, Jorge and Andersen, Ditte Caroline},
title = {Pericardial delta like non‐canonical NOTCH ligand 1 (Dlk1) augments fibrosis in the heart through epithelial to mesenchymal transition},
journal = {Clinical and Translational Medicine},
year = {2024},
doi = {10.1002/ctm2.1565}
}
EUVIMED